Garnet Henderson, Truthout
November 26, 2022
In 2020, a federal judge ruled that the Food and Drug Administration (FDA) must suspend its requirement that patients pick up mifepristone, one of the pills used in medication abortion, in person. After some back-and-forth under the Trump administration, the FDA permanently repealed the rule, which had long been decried by medical experts as unnecessary, in 2021.
This opened the door for providers to send abortion pills by mail in all but the 19 states that outlaw provision of abortion via telemedicine. (Many of those same states now ban abortion entirely.) This regulation change, along with increased popular interest in abortion access following Roe’s overturn, has led to a proliferation of telemedicine companies offering abortion pills. Some of these companies are run by people with prior experience in abortion care and connections in the reproductive health, rights and justice movements; others are not. Regardless, some abortion access advocates are raising concerns about whether the rise of for-profit telemedicine companies is the best way to serve abortion seekers.